These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Asymptomatic hypertrophic myocardiopathy. The arguments against its treatment]. Alfonso F Rev Esp Cardiol; 1995 Aug; 48(8):514-21. PubMed ID: 7644804 [No Abstract] [Full Text] [Related]
65. Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death. Segura-Villalobos F; Hernández-Guerra AI; Wanguemert-Pérez F; Rodríguez-Pérez JC; Mendoza-Lemes H; Barriales-Villa R Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):604-606. PubMed ID: 28073646 [No Abstract] [Full Text] [Related]
66. Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy. Maron BJ; Hecht G; Klues HG; Kunkes SH; Rosenfeld LE; Cecchi F Am J Cardiol; 1993 Aug; 72(3):363-5. PubMed ID: 8342522 [No Abstract] [Full Text] [Related]
67. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features. Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616 [No Abstract] [Full Text] [Related]
71. Sudden death associated with group A streptococcal infection in an 8-year-old girl with undiagnosed hypertrophic cardiomyopathy. Bragonier R; Oades P Postgrad Med J; 1998 Nov; 74(877):673-4. PubMed ID: 10197214 [TBL] [Abstract][Full Text] [Related]
72. Risk Stratification for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Vakrou S; Vlachopoulos C; Gatzoulis KA Arq Bras Cardiol; 2021 Jul; 117(1):157-159. PubMed ID: 34320088 [No Abstract] [Full Text] [Related]
73. Rediscovering the value of exercise in patients with hypertrophic cardiomyopathy. Liu L; Zhu J; Chen H; Hong L; Jiang J Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):758-764. PubMed ID: 36915972 [TBL] [Abstract][Full Text] [Related]
75. Recognizing young people at risk for sudden cardiac death in preparticipation sports physicals. Greene P J Am Acad Nurse Pract; 2000 Jan; 12(1):11-4. PubMed ID: 11033678 [No Abstract] [Full Text] [Related]
76. [Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy]. Lu T; Meng YH; Wang SY Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Jun; 52(6):735-738. PubMed ID: 38880759 [TBL] [Abstract][Full Text] [Related]
77. Syncope and sudden death in hypertrophic cardiomyopathy. Sheldon RS Clin Sci (Lond); 1998 Apr; 94(4):335-6. PubMed ID: 9640336 [No Abstract] [Full Text] [Related]
78. Hypertrophic Cardiomyopathy: Mastering the Multiple Facets of a Complex Disease. Naidu SS; Panza JA Cardiol Clin; 2019 Feb; 37(1):ix-x. PubMed ID: 30447721 [No Abstract] [Full Text] [Related]
79. Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy. Otto CM Heart; 2023 Apr; 109(10):725-727. PubMed ID: 37185235 [No Abstract] [Full Text] [Related]
80. Gray zone problem in athletes. Kasikcioglu E Eur Heart J; 2007 Oct; 28(19):2415-6. PubMed ID: 17670758 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]